Journament

Keyword Connections - montelukast Keywords

Connection Type	Connection
Journals	Applied and environmental microbiology Journal of microbiology (Seoul, Korea) pediatric nephrology (berlin, germany) mmwr morbidity and mortality weekly report emotion (washington, dc) Pulmonary pharmacology & therapeutics current allergy and asthma reports
Research Groups	No Research Group Connected
Bibliographies	[1] The leukotriene receptor antagonist Montelukast can induce adverse skin reactions in asthmatic patients. [2] Correction to: Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis. [3] Yeast viral killer toxin K1 induces specific host cell adaptions via intrinsic selection pressure. [4] Progress Toward Measles Elimination - China, January 2013-June 2019. [5] QuickStats: Percentage* of Adults Aged 18-64 Years Who Had Seen or Talked to a Health Care Professional in the Past 12 Months, by Race/Ethnicity - National Health Interview Survey, 2012-2013 and 2017-2018. [6] "Implications of emotion regulation strategies for empathic concern, social attitudes, and helping behavior": Correction to Lebowitz and Dovidio (2015). [7] Correction to: Basophil Activation Test: Old and New Applications in Allergy. [8] Status of HIV Case-Based Surveillance Implementation - 39 U.S. PEPFAR-Supported Countries, May-July 2019. [9] Erratum: Vol. 68, No. 43. [10] Erratum to: Flavobacterium parvum sp. nov., isolated from soil polluted by sewer water. [11] montelukast in adenoid hypertrophy: its effect on size and symptoms [12] effect of depression on renal function as well as oxidative stress and inflammatory response in patients with diabetic nephropathy [13] The leukotriene receptor antagonist Montelukast can induce adverse skin reactions in asthmatic patients. [14] Development of a biocatalytic process as an alternative to the (-)-DIP-Cl-mediated asymmetric reduction of a key intermediate of montelukast [15] Phase 2 trial of montelukast for prevention of pain in sickle cell disease. [16] montelukast in adenoid hypertrophy: its effect on size and symptoms [17] novel lc method development and validation for simultaneous determination of montelukast and doxofylline in bulk and pharmaceutical dosage forms [18] Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat.